Sarcura: Funding, Investors & Team (Sep 2026)
Sarcura creates a machine platform for the mass production of customized cell therapies in industry. Our goal is to increase the number of doses produced globally for these life-saving, patient-specific cancer treatments from thousands to hundreds of thousands each year while keeping costs low and patient safety high. By bringing bioprocess control down to the cellular level using semiconductor technology, we will revolutionize current production paradigms. AUTOMATE MINIATURIZE INTEGRATE
Sarcura has raised $7.3M across 1 funding round on record, the most recent a Seed of $7.3M announced in Nov 2022.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sarcura Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Sarcura Funding Rounds
Sarcura Founders and Leadership Team
Contact details for the Sarcura team: 1 of 1 has an email address on file.
Start 14-day free trial →Sarcura Funding Compared to Other Biotechnology Startups
Sarcura's latest round of $7.3M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sarcura in Biotechnology and Klosterneuburg
Companies Similar to Sarcura
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell…
VALANX Biotech creates a unique method of attaching proteins to specific sites for use in treatments,…
aTension.life is a company dedicated to improving the diagnosis and treatment of hypertension using precision…
Millions of people worldwide suffer from brain-related issues that can already be addressed with the latest…
Hookipa Biotech is a clinical stage company developing next-generation immunotherapies for infectious…
The patented technology developed by Lignovations allows for the creation of lignin particles in the…
Arkeon Bio is a biotechnology company that captures CO2 from industry and converts inorganic gases into…
Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Sarcura Funding FAQs
What does Sarcura do?
Sarcura creates a machine platform for the mass production of customized cell therapies in industry. Our goal is to increase the number of doses produced globally for these life-saving, patient-specific cancer treatments from thousands to hundreds of thousands each year while keeping costs low and patient safety high. By bringing bioprocess control down to the cellular level using semiconductor technology, we will revolutionize current production paradigms. AUTOMATE MINIATURIZE INTEGRATE
How much funding has Sarcura raised?
Sarcura has raised $7.3M across 1 round on record. The most recent is a Seed of $7.3M announced in Nov 2022.
When did Sarcura last raise funding?
Sarcura's most recent funding round on record is a Seed of $7.3M, announced in Nov 2022.
Who is the CEO of Sarcura?
Daniela Buchmayr is listed as CEO at Sarcura.
Where is Sarcura headquartered?
Sarcura is based in Klosterneuburg, Niederosterreich, Austria.
How many employees does Sarcura have?
Sarcura is in the 11-50 employee band.
How does Sarcura's funding compare to other Biotechnology startups?
Sarcura's latest round of $7.3M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Sarcura Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sarcura is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.